Ledger.Open graph →
SEC Form D · Amendment · filed January 14, 2014

PRIME GENOMICS, INC

Offering
$800K
Sold
$325K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Alan R. Brimm · SAN FRANCISCO, CAPromoterScott R. Greenstone · MILL VALLEY, CADirectorPeter V. Groetzinger · SAN FRANCISCO, CAPromoterThomas W. Loker · SAN FRANCISCO, CAExecSandy C. Shaw · SAN FRANCISCO, CAExec · Director · PromoterRobert R. Tufts · SAN FRANCISCO, CADirector · PromoterMatthew A. Sharp · Old Lyme, CTPromoterMichael P. Neely · New York, NYDirector · PromoterMarita A. Wein · Grand Cayman, Cayman IslandsExec · Director · PromoterPenelope L. Pennington · Saint Louis, MOExecRobert L. Thomas · London, United KingdomDirectorKirk Galiani · McLean, VAPromoterRaymond C. Merritt · Berwyn Heights, MDDirector · PromoterJames A. Tricarico, Jr · Saint Louis, MOExec · Director · PromoterKevin D. Bastien · Saint Louis, MOExecLancaster Investment Management LLP · London, United KingdomDirectorMark D. Fisher · McLean, VAPromoterTimothy Roche · San Diego, CAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗